Pay in 4 interest-free payments of $5.49 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Scholz, R
B-12 - contraindicated in Lebers disease (optic atrophy)
Despite the objective improvements, only 26.7% (Group A) and 14.3% (Group B) rated results "good" or "excellent." This highlights the gap between measurable hair count increases and subjective satisfaction patients often need to see dramatic visual change to feel satisfied, which may require longer treatment or combination approaches
Its interest stems from pre-clinical research showing tissue-repair, anti-inflammatory, cytoprotective and angiogenic effects in animal models
(2023a)
US$ 23.70
US$ 27.10
US$ 25.78
US$ 28.75
US$ 28.14
US$ 25.66
US$ 21.01
